PSYCHO PHARMACOLOGY COMPLETE
QUESTION BANK AND ANSWER KEY 2026
◉ GABA. Answer: a major inhibitory neurotransmitter
◉ tardive dyskinesia. Answer: Involuntary movements of the facial
muscles, tongue, and limbs. Associated with FGA. Irreversible.
◉ carbemazepine. Answer: The "gold standard" for rapid cycling.
◉ aripiprazole, ziprasidone, lurasidone. Answer: Weight neutral
SGA.
◉ spina bifida. Answer: Teratogenic effect associated with valproic
acid.
◉ Epstein's anomaly. Answer: Teratogenic effect associated with
lithium.
◉ Steven Johnson Syndrome (SJS). Answer: Severe blistering of the
skin, with mucous membrane involvement and fever, associated with
lamotrigine.
,◉ ACE/ARB, NSAIDs, diuretics. Answer: Medications that affect
lithium levels
◉ Reduce by half. Answer: Adjustment of lamotrigine dose when
taken with valproic acid.
◉ Inhibitor. Answer: Increases the serum levels of other drugs.
◉ inducer. Answer: Decreases the serum level of other drugs.
◉ sedation. Answer: When a patient complains of being "out of it,"
what side effect are they referring to?
◉ Hyperprolactinemia. Answer: Major s/e of risperidone
(Risperdal) -- an atypical antipsychotic.
◉ Quetiapine (Seroquel). Answer: SGA with more affinity for H1
receptors, causes increased sedation.
◉ older, female, duration of illness, substance abuse. Answer:
Factors that increase the risk of TD?
◉ Tuberofundibular. Answer: Dopamine pathway associated with
hyperprolactinemia
, ◉ clozapine. Answer: Drug of choice for treatment resistant
schizophrenia.
◉ clozapine and lithium. Answer: Medications that reduce SI
incidence.
◉ citalopram. Answer: SSRI associated with QT prolongation and
lethality due to cardiac effects.
◉ fluoxetine. Answer: SSRI approved to treat MDD in teens.
◉ Fluoxetine (Prozac). Answer: Activating SSRI
◉ bupropion. Answer: Antidepressant contraindicated in bulemia.
◉ paroxetine. Answer: SSRI with many severe drug interactions due
to its CYP2D6 inhibition.
◉ lamotrigine. Answer: Mood stabilizer not associated with weight
gain.
QUESTION BANK AND ANSWER KEY 2026
◉ GABA. Answer: a major inhibitory neurotransmitter
◉ tardive dyskinesia. Answer: Involuntary movements of the facial
muscles, tongue, and limbs. Associated with FGA. Irreversible.
◉ carbemazepine. Answer: The "gold standard" for rapid cycling.
◉ aripiprazole, ziprasidone, lurasidone. Answer: Weight neutral
SGA.
◉ spina bifida. Answer: Teratogenic effect associated with valproic
acid.
◉ Epstein's anomaly. Answer: Teratogenic effect associated with
lithium.
◉ Steven Johnson Syndrome (SJS). Answer: Severe blistering of the
skin, with mucous membrane involvement and fever, associated with
lamotrigine.
,◉ ACE/ARB, NSAIDs, diuretics. Answer: Medications that affect
lithium levels
◉ Reduce by half. Answer: Adjustment of lamotrigine dose when
taken with valproic acid.
◉ Inhibitor. Answer: Increases the serum levels of other drugs.
◉ inducer. Answer: Decreases the serum level of other drugs.
◉ sedation. Answer: When a patient complains of being "out of it,"
what side effect are they referring to?
◉ Hyperprolactinemia. Answer: Major s/e of risperidone
(Risperdal) -- an atypical antipsychotic.
◉ Quetiapine (Seroquel). Answer: SGA with more affinity for H1
receptors, causes increased sedation.
◉ older, female, duration of illness, substance abuse. Answer:
Factors that increase the risk of TD?
◉ Tuberofundibular. Answer: Dopamine pathway associated with
hyperprolactinemia
, ◉ clozapine. Answer: Drug of choice for treatment resistant
schizophrenia.
◉ clozapine and lithium. Answer: Medications that reduce SI
incidence.
◉ citalopram. Answer: SSRI associated with QT prolongation and
lethality due to cardiac effects.
◉ fluoxetine. Answer: SSRI approved to treat MDD in teens.
◉ Fluoxetine (Prozac). Answer: Activating SSRI
◉ bupropion. Answer: Antidepressant contraindicated in bulemia.
◉ paroxetine. Answer: SSRI with many severe drug interactions due
to its CYP2D6 inhibition.
◉ lamotrigine. Answer: Mood stabilizer not associated with weight
gain.
